Jerome, Switzerland
It all began with a routine blood analysis. At that stage, there were no physical symptoms or warning signs, but the results showed an elevated PSA (Prostate-Specific Antigen) level. This clinical marker was the first indication that something was wrong and required further investigation.
The diagnosis was established through a precise diagnostic pathway. Following the high PSA result, an MRI determined a PI-RADS 5 score, the highest risk level. This made a biopsy essential, which confirmed an intermediate Gleason score. A PSMA PET-SCAN completed the assessment to accurately evaluate the extent of the situation - especially the absence of metastases - before the intervention. Learning the diagnosis was a profound shock. It instantly shifted daily life toward a clinical reality centered on the necessity of a radical prostatectomy.
My urologist integrated all diagnostic findings into a comprehensive treatment plan. My concerns regarding recovery and long-term prognosis were addressed through a structured pre- and post-operative protocol, which specifically factored in potential outcomes such as biochemical recurrence (BCR).
In my case, the greatest challenge was the profound uncertainty regarding the future. Navigating the stages of hospitalization, the surgery itself, and the subsequent recovery process involved constant unpredictability. The emotional weight of a potential relapse, such as biochemical recurrence (BCR), was and still is a significant burden that accompanies the physical demands of the post-surgery recovery process.
The support from my family, friends, and colleagues was the most critical factor in getting me through this experience. Alongside them, the healthcare professionals - both in private practice and at the hospital - provided a level of care and expertise that truly gave me confidence and supported my mental, emotional, and physical well-being.
I received the best possible care within an exceptionally efficient timeframe. I was diagnosed in September and underwent surgery by December. Throughout the entire process, my urologist, the practitioners at University Hospital Basel, and my surgeon were consistently attentive to my concerns and choices. They maintained full transparency regarding the risks and opportunities at every stage of the treatment. I felt deeply respected and truly heard by the medical team.
To anyone facing a diagnosis today, my core message is this: trust the process. When you are suddenly confronted with high PSA levels and complex clinical scores, the uncertainty can feel overwhelming. However, I found that leaning into the expertise of a transparent medical team and the unwavering support of family, friends, and colleagues provides the stability needed to move forward. Accept the roadmap laid out for you, and focus on each step as it comes.
My experience showed me that efficiency and transparency are the pillars of compassionate care. Moving from diagnosis to surgery in just three months, while being kept fully informed of every risk and opportunity, transformed a frightening situation into a manageable journey. For the healthcare system to be truly person-centered, it must prioritize clear communication and swift action. When a patient feels heard and respected as a partner in their own care, it builds the trust necessary to navigate the challenges of recovery.